April 1, 2026·ManukaBuzzz Editorial
What Each Pricing Tier Actually Buys
A jar at MGO 100 and a jar at MGO 829 differ by an order of magnitude in antibacterial concentration. They also differ by roughly an order of magnitude in price. Where the diminishing returns sit depends on what you are using the honey for.
The tier ladder
Most major manuka brands sell five to seven tiers. Comvita, Manuka Health, and Manuka Doctor all use a similar ladder anchored to UMF or MGO. As of early 2026, the typical lineup looks like this:
| UMF | Approximate MGO | Typical price (8.8 oz, USD) |
|---|---|---|
| 5+ | 83+ | $20 to $30 |
| 10+ | 263+ | $35 to $45 |
| 15+ | 514+ | $50 to $60 |
| 18+ | 696+ | $70 to $90 |
| 20+ | 829+ | $90 to $120 |
| 25+ | 1200+ | $200+ |
The price ladder is not linear. The jump from UMF 15+ to UMF 20+ adds roughly 60 percent to MGO and roughly doubles the price. The jump from 20+ to 25+ adds roughly 45 percent to MGO and more than doubles the price again.
What you are actually paying for at each tier
MGO 30 to 100 (UMF 5+ and below). This is gateway manuka. It is real manuka, but at antibacterial concentrations comparable to many high-quality non-manuka honeys. Useful for daily use as a slightly upscale table honey. Not the right tool for any therapeutic claim.
MGO 250 (UMF 10+). The first tier where the antibacterial activity is meaningfully above what hydrogen-peroxide-based regular honeys deliver. Reasonable for sore throats, post-operative oral comfort, mild topical use on minor cuts. Most people who buy "active" manuka are buying at this tier.
MGO 500 (UMF 15+). The level where the published in vitro antibacterial activity against Staphylococcus aureus and other common pathogens becomes consistent. Most published wound-care studies use grades in this range or higher. The price-to-potency ratio is, for most people, the sweet spot.
MGO 800 to 1000 (UMF 20+). Premium tier. Useful where the higher concentration is genuinely indicated: established wound dressings under medical supervision, persistent oral or skin issues that did not respond at lower grades. The marginal antibacterial benefit over UMF 15+ is real but smaller than the price difference suggests.
MGO 1200+ (UMF 25+). Status tier. The chemistry is real, the rarity is real, but for most uses there is no documented therapeutic benefit over UMF 20+. The price reflects scarcity and gift-market positioning more than additional efficacy per spoon.
Where the diminishing returns sit
In antibacterial terms, the relationship between MGO and bacterial inhibition is roughly linear up to a point and then flattens. The PLOS One study by Johnston and colleagues comparing UMF 5+ to UMF 20+ honeys against a panel of pathogens found that doubling the MGO concentration from 250 to 500 produced a clear improvement in inhibition, but doubling again from 500 to 1000 produced a smaller proportional gain.
For most consumer use, the practical diminishing-returns inflection is around UMF 15+. Beyond that, you are paying for marginal increases that matter in a hospital wound-care context but not in a sore-throat context.
Per-ounce dollar comparison
At the time of writing, a Comvita UMF 15+ at $56.99 for 8.8 oz works out to $6.48 per ounce. A Manuka Health UMF 16+ at $54.49 for the same size is $6.19 per ounce. Comvita UMF 20+ at $115 for 8.8 oz is $13.07 per ounce, double the price for roughly 60 percent more antibacterial concentration. The dollar-per-MGO-unit floor is around UMF 15+ across all major brands.
Practical decision rule
For occasional culinary use or mild sore throat, UMF 10+ is sufficient and the cheapest credible manuka. For consistent daily use as an active honey, UMF 15+ is the price-performance peak. For wound application or persistent problems, UMF 20+ has documented support but should ideally be discussed with a clinician. Anything above UMF 20+ is mostly a status purchase, not an efficacy purchase.
The one tier to avoid for most people: UMF 5+ at near-UMF-10+ prices. The bargain math does not work.